Citation: | YANG Jingru, MA Yuhong, HUANG Dechun, QIAN Hongliang, CHEN Wei. Progress of intelligent-responsive insulin delivery mediated by glucose oxidase[J]. Journal of China Pharmaceutical University, 2021, 52(6): 663-674. DOI: 10.11665/j.issn.1000-5048.20210603 |
[1] |
. J China Pharm Univ (中国药科大学学报),2011,42(2):97-106.
|
[2] |
van Dieren S,Beulens JWJ,van der Schouw YT,et al. The global burden of diabetes and its complications:an emerging pandemic[J]. Eur J Cardiovasc Prev Rehabilitation,2010,17(
|
[3] |
Frizziero L,Calciati A,Torresin T,et al. Diabetic macular edema treated with 577-nm subthreshold micropulse laser:a real-life,long-term study[J]. J Pers Med,2021,11(5):405.
|
[4] |
Ma RJ,Shi LQ. Phenylboronic acid-based glucose-responsive polymeric nanoparticles:synthesis and applications in drug delivery[J]. Polym Chem,2014,5(5):1503-1518.
|
[5] |
Li CY,Huang WL,Qian H. Advances in the research of long-acting strategy of insulin and GLP-1 analogs[J]. J China Pharm Univ (中国药科大学学报),2018,49(6):660-670.
|
[6] |
Chai ZH,Dong HY,Sun XY,et al. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice[J]. Int J Biol Macromol,2020,159:640-647.
|
[7] |
Mo R,Jiang TY,Di J,et al. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery[J]. Chem Soc Rev,2014,43(10):3595-3629.
|
[8] |
Wang J,Wang Z,Yu J,et al. Glucose-responsive insulin and delivery systems:innovation and translation[J]. Adv Mater,2020,32(13):
|
[9] |
Ravaine V,Ancla C,Catargi B. Chemically controlled closed-loop insulin delivery[J]. J Control Release,2008,132(1):2-11.
|
[10] |
Wu Q,Wang L,Yu H,et al. Organization of glucose-responsive systems and their properties[J]. Chem Rev,2011,111(12):7855-7875.
|
[11] |
Zhao L,Wang L,Zhang Y,et al. Glucose oxidase-based glucose-sensitive drug delivery for diabetes treatment[J]. Polymers (Basel),2017,9(7).
|
[12] |
Zhang M,Song CC,Du FS,et al. Supersensitive oxidation-responsive biodegradable PEG hydrogels for glucose-triggered insulin delivery[J]. ACS Appl Mater Interfaces,2017,9(31):25905-25914.
|
[13] |
Dong Y,Wang W,Veiseh O,et al. Injectable and glucose-responsive hydrogels based on boronic acid-glucose complexation[J]. Langmuir,2016,32(34):8743-8747.
|
[14] |
Liu XY,Li C,Lv J,et al. Glucose and H2O2 dual-responsive polymeric micelles for the self-regulated release of insulin[J]. ACS Appl Bio Mater,2020,3(3):1598-1606.
|
[15] |
Gordijo CR,Koulajian K,Shuhendler AJ,et al. Nanotechnology-enabled closed loop insulin delivery device:in vitro and in vivo evaluation of glucose-regulated insulin release for diabetes control[J]. Adv Funct Mater,2011,21(1):73-82.
|
[16] |
Wu Z,Zhang S,Zhang X,et al. Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release[J]. J Pharm Sci,2011,100(6):2278-2286.
|
[17] |
Gu Z,Dang TT,Ma M,et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery[J]. ACS Nano,2013,7(8):6758-6766.
|
[18] |
Anirudhan TS,Nair AS,Nair SS. Enzyme coated beta-cyclodextrin for effective adsorption and glucose-responsive closed-loop insulin delivery[J]. Int J Biol Macromol,2016,91:818-827.
|
[19] |
Kim MY,Kim J. Chitosan microgels embedded with catalase nanozyme-loaded mesocellular silica foam for glucose-responsive drug delivery[J]. ACS Biomater Sci Eng,2017,3(4):572-578.
|
[20] |
Di J,Yu JC,Ye YQ,et al. Engineering synthetic insulin-secreting cells using hyaluronic acid microgels integrated with glucose-responsive nanoparticles[J]. Cell Mol Bioeng,2015,8(3):445-454.
|
[21] |
Fu Y,Liu W,Wang LY,et al. Erythrocyte-membrane-camouflaged nanoplatform for intravenous glucose-responsive insulin delivery[J]. Adv Funct Mater,2018,28(41):1802250.
|
[22] |
Mohammadpour F,Hadizadeh F,Tafaghodi M,et al. Preparation,in vitro and in vivo evaluation of PLGA/chitosan based nano-complex as a novel insulin delivery formulation[J]. Int J Pharm,2019,572:118710.
|
[23] |
Gu Z,Aimetti AA,Wang Q,et al. Injectable nano-network for glucose-mediated insulin delivery[J]. ACS Nano,2013,7(5):4194-4201.
|
[24] |
Zhao L,Xiao C,Wang L,et al. Glucose-sensitive polymer nanoparticles for self-regulated drug delivery[J]. Chem Commun (Camb),2016,52(49):7633-7652.
|
[25] |
Zhou X,Wu H,Long R,et al. Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation[J]. J Nanobiotechnology,2020,18(1):96.
|
[26] |
Tai W,Mo R,Di J,et al. Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin[J]. Biomacromolecules,2014,15(10):3495-3502.
|
[27] |
Zhou K,Wang Y,Huang X,et al. Tunable,ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells[J]. Angew Chem Int Ed Engl,2011,50(27):6109-6114.
|
[28] |
Luo FQ,Chen GJ,Xu W,et al. Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery[J]. Nano Res,2021,14(8):2689-2696.
|
[29] |
Tong ZZ,Zhou JY,Huang RS,et al. Dual-responsive supramolecular self-assembly of inclusion complex of an azobenzene-ended poly(ε-caprolactone) with a water-soluble pillar[6]Arene and its application in controlled drug release[J]. J Polym Sci Part A:Polym Chem,2017,55(15):2477-2482.
|
[30] |
Zuo M,Qian W,Xu Z,et al. Multiresponsive supramolecular theranostic nanoplatform based on pillar[5]Arene and diphenylboronic acid derivatives for integrated glucose sensing and insulin delivery[J]. Small,2018,14(38):
|
[31] |
Lin YH,Hu W,Bai XW,et al. Glucose- and pH-responsive supramolecular polymer vesicles based on host-guest interaction for transcutaneous delivery of insulin[J]. ACS Appl Bio Mater,2020,3(9):6376-6383.
|
[32] |
Ma RJ,Sun XC,Liu XJ,et al. Complex micelles with glucose-responsive shells for self-regulated release of glibenclamide[J]. Aust J Chem,2014,67(1):127.
|
[33] |
Gaballa H,Theato P. Glucose-responsive polymeric micelles via boronic acid-diol complexation for insulin delivery at neutral pH[J]. Biomacromolecules,2019,20(2):871-881.
|
[34] |
Li X,Shang H,Wu W,et al. Glucose-responsive micelles for controlled insulin release based on transformation from amphiphilic to double hydrophilic[J]. J Nanosci Nanotechnol,2016,16(6):5457-5463.
|
[35] |
Chen Y,Li P,Modica JA,et al. Acid-resistant mesoporous metal-organic framework toward oral insulin delivery:protein encapsulation,protection,and release[J]. J Am Chem Soc,2018,140(17):5678-5681.
|
[36] |
Zhang C,Hong S,Liu MD,et al. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery[J]. J Control Release,2020,320:159-167.
|
[37] |
Yang XX,Feng P,Cao J,et al. Composition-engineered metal-organic framework-based microneedles for glucose-mediated transdermal insulin delivery[J]. ACS Appl Mater Interfaces,2020,12(12):13613-13621.
|
[38] |
Jamwal S,Ram B,Ranote S,et al. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery[J]. Int J Biol Macromol,2019,123:968-978.
|
[39] |
Zhang G,Ji Y,Li X,et al. Polymer-covalent organic frameworks composites for glucose and pH dual-responsive insulin delivery in mice[J]. Adv Healthc Mater,2020,9(14):
|
[40] |
Chen WH,Luo GF,Vázquez-González M,et al. Glucose-responsive metal-organic-framework nanoparticles act as "Smart" sense-and-treat carriers [J]. ACS Nano,2018,12(8):7538-7545.
|
[41] |
Patel A,Sant S. Hypoxic tumor microenvironment:opportunities to develop targeted therapies[J]. Biotechnol Adv,2016,34(5):803-812.
|
[42] |
Thambi T,Deepagan VG,Yoon HY,et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery[J]. Biomaterials,2014,35(5):1735-1743.
|
[43] |
Yu JC,Qian CG,Zhang YQ,et al. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery[J]. Nano Lett,2017,17(2):733-739.
|
[44] |
Yu JC,Zhang YQ,Ye YQ,et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery[J]. Proc Natl Acad Sci USA,2015,112(27):8260-8265.
|
[45] |
Thambi T,Deepagan VG,Yoon HY,et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery[J]. Biomaterials,2014,35(5):1735-1743.
|
[46] |
Matsumoto A,Ishii T,Nishida J,et al. A synthetic approach toward a self-regulated insulin delivery system[J]. Angew Chem Int Ed Engl,2012,51(9):2124-2128.
|
[47] |
Bratlie KM,York RL,Invernale MA,et al. Materials for diabetes therapeutics[J]. Adv Healthc Mater,2012,1(3):267-284.
|
[48] |
Ye YQ,Yu JC,Wang C,et al.Microneedles integrated with pancreatic cells and synthetic glucose-signal amplifiers for smart insulin delivery [J]. Adv Mater,2016,28(16):3115-3121.
|
[49] |
Yao Y,Zhao LY,Yang JJ,et al. Glucose-responsive vehicles containing phenylborate ester for controlled insulin release at neutral pH[J]. Biomacromolecules,2012,13(6):1837-1844.
|
[50] |
Wang J,Ye Y,Yu J,et al. Core-shell microneedle gel for self-regulated insulin delivery[J]. ACS Nano,2018,12(3):2466-2473.
|
[51] |
Huang Q,Wang L,Yu H,et al. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy[J]. J Control Release,2019,305:50-64.
|
[52] |
Hu XL,Yu JC,Qian CG,et al. H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery[J]. ACS Nano,2017,11(1):613-620.
|
[53] |
Hei MY,Wu HJ,Fu Y,et al. Phenylboronic acid functionalized silica nanoparticles with enlarged ordered mesopores for efficient insulin loading and controlled release[J]. J Drug Deliv Sci Technol,2019,51:320-326.
|
[54] |
Xu B,Jiang G,Yu W,et al. H2O2-Responsive mesoporous silica nanoparticles integrated with microneedle patches for the glucose-monitored transdermal delivery of insulin[J]. J Mater Chem B,2017,5(41):8200-8208.
|
[55] |
Yoshida K,Awaji K,Shimizu S,et al. Preparation of microparticles capable of glucose-induced insulin release under physiological conditions[J]. Polymers,2018,10(10):1164.
|
[56] |
Tong ZZ,Zhou JY,Zhong JX,et al. Glucose- and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats[J]. ACS Appl Mater Interfaces,2018,10(23):20014-20024.
|
[57] |
Wang YX,Fan YT,Zhang MH,et al. Glycopolypeptide nanocarriers based on dynamic covalent bonds for glucose dual-responsiveness and self-regulated release of insulin in diabetic rats[J]. Biomacromolecules,2020,21(4):1507-1515.
|
[58] |
Hou L,Zheng YZ,Wang YC,et al. Self-regulated carboxyphenylboronic acid-modified mesoporous silica nanoparticles with “touch switch” releasing property for insulin delivery[J]. ACS Appl Mater Interfaces,2018,10(26):21927-21938.
|
[59] |
Zhang Y,Wang J,Yu J,et al. Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade-triggered insulin delivery[J]. Small,2018,14(14):
|
[60] |
Liu F,Bai L,Zhang H,et al. Smart H2O2-responsive drug delivery system made by halloysite nanotubes and carbohydrate polymers[J]. ACS Appl Mater Interfaces,2017,9(37):31626-31633.
|
[61] |
Shen D,Yu HJ,Wang L,et al. Glucose-responsive hydrogel-based microneedles containing phenylborate ester bonds and N-isopropylacrylamide moieties and their transdermal drug delivery properties[J]. Eur Polym J,2021,148:110348.
|
[62] |
Wang C,Ye YQ,Sun WJ,et al. Red blood cells for glucose-responsive insulin delivery[J]. Adv Mater,2017,29(18):1606617.
|
[63] |
Sokolovska J,Isajevs S,Baumane L,et al. Enhanced expression of xanthine oxidase and NO synthases causing the overproduction of NO in kidneys of diabetic animals can be reduced by 1,4-dihydropyridines[J]. Nitric Oxide,2013,31:
|
[1] | TAO Junjie, YANG Jie, WEN Xiaodong. Studies on the chemical constituents in the aerial parts of Paris polyphylla var. Yunnanensis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 454-460. DOI: 10.11665/j.issn.1000-5048.20200410 |
[2] | WANG Xiaoying, WANG Xiaying, QIU Liangzhen, OUYANG Huizhi, XU Wei. Cytotoxicity and cellular uptake of paclitaxel-loaded carboxymethyl chitosan-rhein polymeric micelles in MCF-7 cells[J]. Journal of China Pharmaceutical University, 2020, 51(1): 33-37. DOI: 10.11665/j.issn.1000-5048.20200106 |
[3] | CHENG Weihua, WANG Wenqian, SHANG Hai, ZHANG Hongwu, GUO Qiang, CHEN Hong, ZOU Zhongmei. Synthesis and cytotoxicity study of cembrane triazole derivatives[J]. Journal of China Pharmaceutical University, 2018, 49(1): 56-63. DOI: 10.11665/j.issn.1000-5048.20180108 |
[4] | TANG Yong, LIAO Shengrong, LI Jinsheng, LIU Yonghong. Design, synthesis and cytotoxic activities of fluorine-containing 2, 5-diketopiperazine derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(4): 412-421. DOI: 10.11665/j.issn.1000-5048.20160405 |
[5] | SUN Hao, YANG Jiapei, MAO Yong, WANG Dandan, YU Feng. Involvement of Fas-dependent pathway in rhein-induced apoptosis of HK-2 cells[J]. Journal of China Pharmaceutical University, 2015, 46(4): 469-475. DOI: 10.11665/j.issn.1000-5048.20150414 |
[6] | WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403 |
[7] | FEI Jia, SUN Min-jie, PING Qi-neng, ZHANG Can. Preparation,characterization and safety evaluation for N-octyl-N-quaternary ammonium chitosan/CMCNa composite micelles[J]. Journal of China Pharmaceutical University, 2012, 43(4): 318-324. |
[8] | SHEN Yan, LI Qian, FAN Da, LI Rui-jun, TU Jia-sheng. Influencing factors of hydrophobic modified hyaluronic acid-based cationic micelles and cell targeting in siRNA transfection[J]. Journal of China Pharmaceutical University, 2012, 43(2): 124-129. |
[9] | GUO Zhong, ZHAO Jin, MA Jian-xiu, FU Si-wu. Effects of toxin A from Clostridium difficile on SMMC-7721 cells proliferation and apoptosis[J]. Journal of China Pharmaceutical University, 2009, 40(3): 250-253. |
[10] | Structure-Cytotoxic Activity Relationships of Diterpenoid Tanshinones from Salvias[J]. Journal of China Pharmaceutical University, 2002, (1): 8-14. |